Global Crohn's Disease Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Crohn's Disease Market was valued at $12.1 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 4.1% CAGR, to an estimated market size of $14.8 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global Crohn's disease market encompasses the pharmaceutical treatments, diagnostic procedures, and surgical interventions used to manage this chronic inflammatory bowel disease (IBD). The scope includes biologic therapies, biosimilars, immunosuppressants, and corticosteroids, as well as diagnostic tools like colonoscopy and surgical techniques such as resection.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Crohn's Disease Market in the period 2025-30:
- The market is experiencing a significant shift toward targeted biologic agents and interleukin inhibitors as first-line treatments for moderate-to-severe cases.
- The rapid entry of biosimilars is creating competitive pricing pressure on established blockbuster drugs like Humira while expanding patient access.
- Adoption of the 'Treat to Target' strategy is moving clinical focus from simple symptom management to objective endoscopic and biomarker-led healing.
- Rising global prevalence of IBD, particularly in urbanizing regions and among pediatric populations, is driving long-term demand for maintenance therapies.
- Innovation in oral small molecule therapies is providing patients with more convenient, non-injectable alternatives to traditional parenteral biologics.
- Increased investment in personalized medicine is allowing clinicians to tailor treatments based on individual genetic risk profiles and gut microbiota composition.
- The integration of digital health tools and telehealth is improving outpatient monitoring and patient engagement in chronic disease management.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Biologics and Biosimilars
- Conventional Pharmaceuticals
- Diagnostics and Surgery